Click a link below to view the mailing archive as if it had been sent to you.
| 2023-11-30 12:15 | | AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field and more... |
| 2023-11-30 00:15 | | Boehringer Ingelheim to collaborate with Phenomic AI on stroma-rich cancers and more... |
| 2023-11-29 12:15 | | FDA kicks off review of Karuna’s schizophrenia drug KarXT and more... |
| 2023-11-29 00:15 | | Teva drops patent case against Lilly after two Ajovy patents deemed invalid and more... |
| 2023-11-28 12:15 | | Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators and more... |
| 2023-11-23 00:15 | | First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study and more... |
| 2023-11-22 12:15 | | This Startup Raised $38 Million To Fill One Of The Biggest Gaps In Drug Discovery and more... |
| 2023-11-22 00:15 | | With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics and more... |
| 2023-11-21 12:15 | | NeoImmuneTech receives orphan drug status for NT-I7 to treat ARS and more... |
| 2023-11-21 00:15 | | Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus and more... |
| 2023-11-20 12:15 | | Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast and more... |
| 2023-11-20 00:15 | | MSLs rejoice, overtaking sales reps as pharma’s prime information conveyors and more... |
| 2023-11-17 12:15 | | Merck Expands Keytruda’s Label as a First-Line Option for Gastric Cancer and more... |
| 2023-11-17 00:15 | | Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine and more... |
| 2023-11-16 12:15 | | Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff and more... |
| 2023-11-16 00:15 | | A year after Roche's Alzheimer's failure, scientists reflect on what could have been and more... |
| 2023-11-15 12:15 | | Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience and more... |
| 2023-11-15 00:15 | | UnitedHealth faces class action lawsuit over algorithmic care denials in Medicare Advantage plans and more... |
| 2023-11-14 12:15 | | Pharma asks 'what’s up, doc?' as industry seeks to get inside the heads of HCPs in 2024 and more... |
| 2023-11-14 00:15 | | Capturing COVID: Biopharma through the lens during the pandemic and more... |
| 2023-11-13 12:15 | | Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines and more... |
| 2023-11-13 00:15 | | Wegovy cuts risk of heart attacks in milestone cardiovascular trial and more... |
| 2023-11-11 00:15 | | Acutus laying off 65% of employees to focus solely on Medtronic heart device deal and more... |
| 2023-11-10 12:15 | | Neurocrine Hit with Back-to-Back Phase II Failures in Neuropsychiatry and more... |
| 2023-11-10 00:15 | | How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets and more... |
| 2023-11-09 12:15 | | AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug and more... |
| 2023-11-09 00:15 | | FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management and more... |
| 2023-11-08 12:15 | | Lumos stock jumps as phase 2 results bring first oral growth hormone drug closer to market and more... |
| 2023-11-08 00:15 | | Flagship expands into Asia-Pacific with new Singapore hub and more... |
| 2023-11-07 12:15 | | As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations and more... |
| 2023-11-07 00:15 | | Krystal's topical gene therapy gains steam, prompting analyst group to boost sales projection and more... |
| 2023-11-06 12:15 | | XBI biotech index rises, giving investors a shred of hope and more... |
| 2023-11-06 00:15 | | How did the pharmaceutical industry treat artificial intelligence in Q3 2023 filings? and more... |
| 2023-11-03 12:15 | | AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data and more... |
| 2023-11-03 00:15 | | Sarepta enjoys early sales ramp for DMD gene therapy, maintains confidence in label expansion and more... |
| 2023-11-02 12:15 | | Bancel suggests Moderna could be open to out-licensing if sales struggle and more... |
| 2023-11-02 00:15 | | BioMarin’s longtime CEO Jean-Jacques Bienaimé hands the reins to Genentech’s Alexander Hardy and more... |
| 2023-11-01 12:15 | | GSK outpaces Pfizer in RSV vaccine market and more... |
| 2023-11-01 00:15 | | Roivant’s $7B Roche deal was a ‘moment of opportunity,’ CEO says and more... |
